Literature DB >> 26870347

Effect of 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzene-sulfonamide on calcium influx in three contraction models.

Elżbieta Grześk1, Katarzyna Szadujkis-Szadurska2, Michał Wiciński2, Bartosz Malinowski2, Thabit A Sinjab2, Barbara Tejza1, Maciej Pujanek2, Ewa Janiszewska2, Anna Kopczyńska2, Grzegorz Grześk2.   

Abstract

2,4,6-Trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide (m-3M3FBS) activates phospholipase C and stimulates apoptosis; however, in smooth muscle cells it may increase the perfusion pressure. The main aim of the present study was to evaluate the physiological effect of direct stimulation of phospholipase C on vascular smooth muscle reactivity using three contraction models. Experiments were performed on the isolated and perfused tail artery of Wistar rats. The contraction force in the present model was measured by an increased level of perfusion pressure with a constant flow. Concentration-response curves (CRCs) obtained for phenylephrine, arg-vasopressin, mastoparan-7 and Bay K8644 presented a sigmoidal association. In comparison to the control curves, CRCs in the presence of m-3M3FBS were significantly shifted to the left except for Bay K8644. Analyses of calcium influx suggest that in the presence of m-3M3FBS the calcium influx from intra- and extracellular calcium stores was significantly higher. The results of the present experiments suggest that m-3M3FBS significantly increases the reactivity of vascular smooth muscle stimulated with metabotropic receptors or G-protein by an increase in calcium influx from intra- and extracellular calcium stores. The current knowledge regarding the apoptotic pathway shows the significance of calcium ions involved in this process, thus, m-3M3FBS may induce apoptosis by an increase of cytoplasmic calcium concentration; however, simultaneously, the use of this mechanism in therapy must be preceded by a molecular modification that eliminates a possible vasoconstriction effect.

Entities:  

Keywords:  2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide; mastoparan-7; phenylephrine; phospholipase C; vasopressin

Year:  2015        PMID: 26870347      PMCID: PMC4726898          DOI: 10.3892/br.2015.543

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  29 in total

1.  Subcellular localization of phospholipase C isoforms in vascular smooth muscle.

Authors:  Edward F LaBelle; Kenneth Wilson; Erzsébet Polyák
Journal:  Biochim Biophys Acta       Date:  2002-08-08

2.  Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.

Authors:  G Powis; M J Seewald; C Gratas; D Melder; J Riebow; E J Modest
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

3.  Zinc homeostasis in C6 glioma cells: phospholipase C activity regulates cellular zinc export.

Authors:  Sven Jansen; Jürgen Arning; Detmar Beyersmann
Journal:  Biol Trace Elem Res       Date:  2005       Impact factor: 3.738

4.  Phospholipase C beta 2 in vascular smooth muscle.

Authors:  E F LaBelle; F Polyák
Journal:  J Cell Physiol       Date:  1996-11       Impact factor: 6.384

Review 5.  Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate.

Authors:  Byung-Chang Suh; Bertil Hille
Journal:  Curr Opin Neurobiol       Date:  2005-06       Impact factor: 6.627

6.  Inhibition of a background potassium channel by Gq protein alpha-subunits.

Authors:  Xiangdong Chen; Edmund M Talley; Nitin Patel; Ana Gomis; William E McIntire; Biwei Dong; Félix Viana; James C Garrison; Douglas A Bayliss
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

7.  Identification of a compound that directly stimulates phospholipase C activity.

Authors:  Yoe-Sik Bae; Taehoon G Lee; Jun Chul Park; Jung Ho Hur; Youndong Kim; Kyun Heo; Jong-Young Kwak; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Pharmacol       Date:  2003-05       Impact factor: 4.436

8.  Phospholipase C activator m-3M3FBS affects Ca2+ homeostasis independently of phospholipase C activation.

Authors:  Jelena Krjukova; Tomas Holmqvist; Alexander S Danis; Karl E O Akerman; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

9.  Guanylate cyclase activators influence reactivity of human mesenteric superior arteries retrieved and preserved in the same conditions as transplanted kidneys.

Authors:  M Slupski; L Szadujkis-Szadurski; G Grześk; R Szadujkis-Szadurski; K Szadujkis-Szadurska; Z Wlodarczyk; M Masztalerz; I Piotrowiak; M Jasiński
Journal:  Transplant Proc       Date:  2007-06       Impact factor: 1.066

10.  Calcium blockers inhibit cyclosporine A-induced hyperreactivity of vascular smooth muscle cells.

Authors:  Grzegorz Grześk; Michał Wiciński; Bartosz Malinowski; Elżbieta Grześk; Sławomir Manysiak; Grażyna Odrowąż-Sypniewska; Nasser Darvish; Maciej Bierwagen
Journal:  Mol Med Rep       Date:  2012-03-26       Impact factor: 2.952

View more
  2 in total

1.  2,4,6-Trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide increases calcium influx in lipopolisaccharide-pre-treated arteries.

Authors:  Elżbieta Grześk; Katarzyna Szadujkis-Szadurska; Elżbieta Bloch-Bogusławska; Michał Wiciński; Bartosz Malinowski; Sylwia KołTan; Barbara Tejza; Maciej Pujanek; Grzegorz GrześK
Journal:  Exp Ther Med       Date:  2016-12-19       Impact factor: 2.447

2.  Anti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model.

Authors:  Michał Wiciński; Bartosz Malinowski; Mateusz M Węclewicz; Elżbieta Grześk; Grzegorz Grześk
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.